A preliminary study has revealed that an investigational drug may help increase protein levels in babies with spinal muscular atrophy.
Browsing: Cognitive/neurodegenerative disorders
In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
We bring together Parkinson’s advances from across research and industry from the year so far.
In one of the largest studies of its kind, researchers reveal that the number of traumatic brain injuries and severity could heighten the risk of dementia.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.
A recent study has reported that long-term consumption of caffeine has negative effects for Alzheimer’s disease, potentially worsening the neuropsychiatric symptoms in those affected by the disorder.
Naomi Hartopp (KCL) reports on the Early Careers Day at the ARUK Conference 2018.